Sort
46,585 grants matching “heart failure”
Project 1: Implications of blood cell heterogeneity for CV disease
$392,800David T Scadden · Massachusetts General Hospital · P01 · FY2021 · HL
Defining Novel Cardiovascular Mechanisms For TKI Induced Excitability
$392,797Sakima Ahmad Smith · Ohio State University · R01 · FY2024 · HL
Protein kinase C-delta actions in cardiomyocytes
$392,783Susan F Steinberg · Columbia University Health Sciences · R01 · FY2012 · HL
Targeting Metabolism To Stimulate Adult Heart Regeneration
$392,783Ahmed I Mahmoud · University Of Wisconsin-Madison · R56 · FY2021 · HL
Staphylococcus aureus Infections in VAD Patients
$392,773Columbia University Health Sciences · P50 · FY2005 · HL
microRNA mediation of Endothelial Progenitor Cell function in Myocardial Ichemia
$392,768Prasanna Krishnamurthy · Methodist Hospital Research Institute · R01 · FY2015 · HL
Mechanism of Staphylocoagulase-activated Blood Clotting
$392,750Paul E. Bock · Vanderbilt University Medical Center · R01 · FY2016 · HL
ROLE OF P38 MAPK AND PP2C IN ISCHEMIC INJURY AND PROTECTION
$392,747Yibin Wang · University Of California Los Angeles · P01 · FY2009 · HL
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,710Ioannis Karakikes · Stanford University · R01 · FY2018 · HL
Ca and InsP3 Receptor Signaling in Cardiac Myocytes
$392,701Donald M Bers · University Of California At Davis · P01 · FY2013 · HL
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,696Ioannis Karakikes · Stanford University · R01 · FY2019 · HL
Cardiovascular disease (CVD) and the endothelial bone marrow niche: Project 2
$392,687Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2021 · HL
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,682Ioannis Karakikes · Stanford University · R01 · FY2020 · HL
Nanowired humam cardiac organoid derived exosomes for heart repair
$392,669Ying Mei · Clemson University · R01 · FY2023 · HL
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine
$392,667Ioannis Karakikes · Stanford University · R01 · FY2021 · HL
Pathophysiological role of prorenin in CKD
$392,631Alfred K. Cheung · University Of Utah · R01 · FY2014 · DK
Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy
$392,587Patricia Kim Phuong Nguyen · Stanford University · R01 · FY2019 · HL
Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy
$392,582Patricia Kim Phuong Nguyen · Stanford University · R01 · FY2018 · HL
Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy
$392,576Patricia Kim Phuong Nguyen · Stanford University · R01 · FY2017 · HL
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America
$392,563Dennis M. McNamara · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · MD
Zebrafish Assays Predictive for Cardiotoxicity(RMI)
$392,547Calum A. Macrae · Massachusetts General Hospital · R21 · FY2007 · GM
Polestriding versus Walking for PAD Rehabilitation
$392,538Eileen G Collins · University Of Illinois At Chicago · R01 · FY2009 · NR
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial
$392,519Anil Sapru · University Of California, San Francisco · R01 · FY2014 · HL
PI3K-gamma regulates T cell mediated alloimmunity
$392,516Reza Abdi · Brigham And Women'S Hospital · R01 · FY2019 · HL
PI3K-gamma regulates T cell mediated alloimmunity
$392,516Reza Abdi · Brigham And Women'S Hospital · R01 · FY2020 · HL